![T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia | Journal for ImmunoTherapy of Cancer T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/5/e002509/F1.large.jpg)
T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia | Journal for ImmunoTherapy of Cancer
![Caprico Biotechnologies 104025 CD33 PE Antibody, Clone WM53, Mouse IgG1,k, 100 Tests/Unit - 55-833LB | Genesee Scientific Caprico Biotechnologies 104025 CD33 PE Antibody, Clone WM53, Mouse IgG1,k, 100 Tests/Unit - 55-833LB | Genesee Scientific](https://geneseesci.com/productimages_new/55-833L.webp)
Caprico Biotechnologies 104025 CD33 PE Antibody, Clone WM53, Mouse IgG1,k, 100 Tests/Unit - 55-833LB | Genesee Scientific
![Caracterización de CD33 en células NK y linfocitos T humanos: CD33 un importante marcador en Leucemias (Spanish Edition) - Pérez Oliva, Ana Belén: 9783846565858 - AbeBooks Caracterización de CD33 en células NK y linfocitos T humanos: CD33 un importante marcador en Leucemias (Spanish Edition) - Pérez Oliva, Ana Belén: 9783846565858 - AbeBooks](https://pictures.abebooks.com/isbn/9783846565858-us.jpg)
Caracterización de CD33 en células NK y linfocitos T humanos: CD33 un importante marcador en Leucemias (Spanish Edition) - Pérez Oliva, Ana Belén: 9783846565858 - AbeBooks
![Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design | Journal for ImmunoTherapy of Cancer Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/9/e003149/F7.large.jpg)